The deal, worth around $75 million, highlights growing commercial demand for new ways of simulating and designing drugs as well as developing new materials.
WSJ News Exclusive | SandboxAQ Buys Good Chemistry, Melding AI and Quantum Tech for Drug Discovery
By 
Add A Comment